1.    Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al.

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study

JAMA Oncol. 2018 Nov 1;4(11):1553-1568.

2.    Allemani C, Matsuda T, Di Carlo V, et al.

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Lancet. 2018 Mar 17;391(10125):1023-1075.

3.    Salimzadeh H, Delavari F, Sauvaget C, et al.

Annual Trends of Gastrointestinal Cancers Mortality in Iran During 1990-2015; NASBOD Study.

Arch Iran Med. 2018 Feb 1;21(2):46-55.

4.    Salimzadeh H, Khabiri R, Khazaee-Pool M, et al.

Motivational interviewing and screening colonoscopy in high-risk individuals. A randomized controlled trial.

Patient Educ Couns. 2018 Jun;101(6):1082-1087.

5.    Mansori K, Mosavi-Jarrahi A, Ganbary Motlagh A, et al.

Exploring Spatial Patterns of Colorectal Cancer in Tehran City, Iran.

Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1099-1104.

6.    Mansori K, Solaymani-Dodaran M, Mosavi-Jarrahi A, et al.

Spatial Inequalities in the Incidence of Colorectal Cancer and Associated Factors in the Neighborhoods of Tehran, Iran: Bayesian Spatial Models.

J Prev Med Public Health. 2018 Jan;51(1):33-40.

7.    Salimzadeh H, Bishehsari F, Sauvaget C, et al.

Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.

Arch Iran Med. 2017 Dec 1;20(12):726-733.

8.    Salimzadeh H, Bishehsari F, Sauvaget C, et al.

Colon cancer screening by fecal immunochemical testing in Iran.

Annals of Oncology, Volume 28, Issue suppl_5, Sep 2017, https://doi.org/10.1093/annonc/mdx383.002.

9.    Majidi A, Majidi S, Salimzadeh S, et al.

Cancer Screening Awareness and Practice in a Middle Income Country; A Systematic Review from Iran.

Asian Pac J Cancer Prev. 2017 Dec 28;18(12):3187-3194.

10.    Javadinasab H, Daroudi R, Salimzadeh H, et al.

Cost-effectiveness of Screening Colonoscopy in Iranian High Risk Population.

Arch Iran Med. 2017 Sep;20(9):564-571.

11.    Majidi A, Salimzadeh H, Beiki O, et al.

Cancer research priorities and gaps in Iran: the influence of cancer burden on cancer research outputs between 1997 and 2014.

Public Health. 2017 Mar;144:42-47.

12.    Bastaminejad S, Taherikalani M, Ghanbari R, et al.

Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.

Iran Biomed J. 2017 Mar;21(2):106-13.

13.    Vahdatimanesh Z, Zendehdel K, Kbari Sari AA, et al.

Economic burden of colorectal cancer in Iran in 2012.

Med J Islam Repub Iran. 2017 Dec 20;31:115.

14.    Khorrami S, Zavaran Hosseini A, et al.

MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer  cells.

Tumour Biol. 2017 May;39(5):1010428317698365.

15.    Salimzadeh H, Bishehsari F, Delavari A, et al.

Cancer risk awareness and screening uptake in individuals at higher risk for colon cancer: a cross-sectional study.

BMJ Open. 2016 Dec 20;6(12):e013833.

16.    Salimzadeh H, Bishehsari F, Amani M, et al.

Advanced colonic neoplasia in the first degree relatives of colon cancer patients: A colonoscopy-based study.

Int J Cancer. 2016 Nov 15;139(10):2243-51.

17.    Salimzadeh H, Delavari A, Amani M, et al.

Screening colonoscopy in family members of patients with colorectal cancer: A population-based study in Iran.

Annals of Oncology, Volume 27, Issue suppl_6, Oct 2016, 1340P.

18.    Salimzadeh H, Delavari A, Majidi A, et al.

Su1046 Risk Awareness, and Cancer Knowledge in First Degree Relatives of Patients with Colon Cancer.

Gastroentology. Volume 150, Issue 4, Suppl_1, Apr 2016. Page S455.

19.    Armengol G, Sarhadi VK, Ghanbari R, et al.

Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing.

J Mol Diagn. 2016 Jul;18(4):471-9.

20.    Ghanbari R, Mosakhani N, Sarhadi VK, et al.

Simultaneous Underexpression of let-7a-5p and let-7f-5p microRNAs in Plasma and Stool Samples  from Early Stage Colorectal Carcinoma.

Biomark Cancer. 2016 Jan 12;7(Suppl 1):39-48.

21.    Salimzadeh H, Najafipour H, Mirzaiepour F, et al.

Prevalence of Active and Passive Smoking among Adult Population: Findings of a Population-Based Survey in Kerman (KERCADRS), Iran.

Addict Health. 2016 Winter;8(1):16-24.

22.    Delavari A, Salimzadeh H, Bishehsari F, et al.

Mean Polyp per Patient Is an Accurate and Readily Obtainable Surrogate for Adenoma Detection Rate: Results from an Opportunistic Screening Colonoscopy Program.

Middle East J Dig Dis. 2015 Oct;7(4):214-9.

23.    Moossavi S, Salimzadeh H, Katoonizadeh A, et al.

Physicians' Knowledge and Attitude Towards Fecal Microbiota Transplant in Iran.

Middle East J Dig Dis. 2015 Jul;7:155-60.

24.    Moossavi S, Bishehsari F, Ansari R, et al.

Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.

Middle East J Dig Dis. 2015 Jul;7:177-80.

25.    Ghanbari R, Mosakhani N, Asadi J, at al.

Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma.

Iran J Cancer Prev. 2015 May;8(3):e2329.

26.    Ghanbari R, Mosakhani N, Asadi J, et al.

Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.

Cancer Biomark. 2015;15(2):189-95.

27.    Khorrami S, Zavaran Hosseini A, Mowla SJ, Malekzadeh R.

Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line.

Iran J Cancer Prev. 2015 Oct;8(5):e3446.

28.    Delavari A, Bishehsari F, Salimzadeh H, et al.

Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence.

BMC Gastroenterol. 2014 Nov 18;14:196.

29.    Delavari A, Mardan F, Salimzadeh H, et al.

Characteristics of colorectal polyps and cancer; a retrospective review of colonoscopy data in iran.

Middle East J Dig Dis. 2014 Jul;6(3):144-50.

30.    Bishehsari F.

Race in colorectal cancer screening strategies: a solid determinant factor or a "moving target"?

Gastroenterology. 2014 Dec;147(6):1440.

31.    Bishehsari F, Mahdavinia M, Vacca M, et al.

Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.

World J Gastroenterol. 2014 May 28;20(20):6055-72.

32.    Moossavi S.

The necessity for an Iranian gut microbiome initiative.

Middle East J Dig Dis. 2014 Apr;6(2):109-10.

33.    Salimzadeh H, Eftekhar H, Delavari A, et al.

Psycho-social Determinants of Colorectal Cancer Screening in Iran.

Int J Prev Med. 2014 Feb;5(2):185-90.

34.    Modirian M, Rahimzadeh S, Cheraghi Z, et al.

Quality evaluation  of national cancer registry system in Iran: study protocol.

Arch Iran Med. 2014 Mar;17(3):193-7.

35.    Salimzadeh H, Ardeshir Larijani F, et al.

The trend of national and sub-national burden of gastrointestinal and liver diseases in Iran 1990 to 2013; study protocol.

Arch Iran Med. 2014 Jan;17(1):33-53.

36.    Salimzadeh H, Eftekhar H, Majdzadeh R, et al.

Effectiveness of a theory-based intervention to increase colorectal cancer screening among Iranian health club members: a randomized trial.

J Behav Med. 2014 Oct;37(5):1019-29.

37.    Moossavi S, Zhang H, Sun J, Rezaei N.

Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.

Expert Rev Clin Immunol. 2013 May;9(5):409-22.

38.    Moossavi S, Ansari R.

Intestinal stem cell imaging in colorectal cancer screening.

J Stem Cells Regen Med. 2013 Nov 15;9(2):37-9.

39.    Mirzazadeh A, Salimzadeh H, Arabi M, et al.

Trends of Obesity in Iranian Adults from 1990s to late 2000s; a Systematic Review and Meta-analysis.

Middle East J Dig Dis. 2013 Jul;5(3):151-7.

40.    Salimzadeh H, Delavari A, Montazeri A, et al.

Knowledge and practice of Iranians toward colorectal cancer, and barriers to screening.

Int J Prev Med. 2012 Jan;3(1):29-35.

41.    Moossavi S, Bishehsari F.

Inflammation in sporadic colorectal cancer.

Arch Iran Med. 2012 Mar;15(3):166-70.

42.    Esposito DL, Aru F, Lattanzio R, et al.

The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer.

PLoS One. 2012;7(4):e36190.

43.    Sohrabi S, Malekzadeh R, Ansari R, et al.

Squatting and risk of colorectal cancer:a case-control study.

Middle East J Dig Dis. 2012 Jan;4(1):23-7.

44.    Salimzadeh H, Eftekhar H, Majdzadeh R, et al.

More than half of senior residents in Tehran have never heard about colorectal cancer screening. Asian Pac J Cancer Prev. 2011;12(11):2851-6.

45.    Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R.

Epidemiology and molecular genetics of colorectal cancer in iran: a review.

Arch Iran Med. 2009 Mar;12(2):161-9.

46.    Mahdavinia M, Bishehsari F, Verginelli F, et al.

P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.

J Cell Physiol. 2008 Aug;216(2):543-50.

47.    Bishehsari F, Mahdavinia M, Malekzadeh R, et al.

Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin.

Ann Oncol. 2006 Jun;17 Suppl 7:vii91-6.

48.    Ansari R, Mahdavinia M, Sadjadi A, et al.

Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry.

Cancer Lett. 2006 Aug 18;240(1):143-7.

49.    Mahdavinia M, Bishehsari F, Ansari R, et al.

Family history of colorectal cancer in Iran.

BMC Cancer. 2005 Sep 5;5:112.

50.   Nasseri-Moghaddam S, Mohamadnejad M, Malekzadeh R, at al.

Images of interest Gastrointestinal: polypoid arteriovenous malformation of the colon. J

Gastroenterol Hepatol. 2004 Dec;19(12):1419.

51.    Sadjadi A, Malekzadeh R, Derakhshan MH, et al.

Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran.

Int J Cancer. 2003 Oct 20;107(1):113-8.

52.    Mohamadnejad M, Babai M, Bidari A, et al.

Adenocarcinoma of the colon associated with sarcoidosis.

MedGenMed. 2003 Mar 3;5(1):6.

Related storys